Absci Corporation

NasdaqGS ABSI

Absci Corporation Price to Book Ratio (P/B) on February 06, 2025: 2.58

Absci Corporation Price to Book Ratio (P/B) is 2.58 on February 06, 2025, a 24.74% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Absci Corporation 52-week high Price to Book Ratio (P/B) is 3.20 on April 09, 2024, which is 23.77% above the current Price to Book Ratio (P/B).
Absci Corporation 52-week low Price to Book Ratio (P/B) is 1.40 on November 21, 2024, which is -45.97% below the current Price to Book Ratio (P/B).
Absci Corporation average Price to Book Ratio (P/B) for the last 52 weeks is 2.11.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

NasdaqGS: ABSI

Absci Corporation

CEO	Mr. Sean McClain
IPO Date	July 22, 2021
Location	United States
Headquarters	18105 SE Mill Plain Boulevard
Employees	155
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies Fintech

Description

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Key trends

Past 5 years